New Lung Organoids Mimic Full-sized Lungs
News May 12, 2017 | Original story from Columbia University Medical Center
New lung “organoids”—tiny 3-D structures that mimic features of a full-sized lung—have been created from human pluripotent stem cells by researchers at Columbia University Medical Center (CUMC). The team used the organoids to generate models of human lung diseases in a lab dish, which could be used to advance our understanding of a variety of respiratory diseases.
Organoids are 3-D structures containing multiple cell types that look and function like a full-sized organ. By reproducing an organ in a dish, researchers hope to develop better models of human diseases and find new ways of testing drugs and regenerating damaged tissue.
“Researchers have taken up the challenge of creating organoids to help us understand and treat a variety of diseases,” said Hans-Willem Snoeck, PhD, professor of medicine (in microbiology & immunology) at Columbia and lead investigator of the study. “But we have been tested by our limited ability to create organoids that can replicate key features of human disease.”
The lung organoids created in Dr. Snoeck’s lab are the first to include branching airway and alveolar structures, similar to human lungs.
To demonstrate the functionality of the organoids, the researchers showed that the organoids reacted in much the same way as a real lung does when infected with respiratory syncytial virus (RSV). Additional experiments revealed that the organoids also responded as a human lung would when carrying a gene mutation linked to pulmonary fibrosis.
RSV is a major cause of lower respiratory tract infection in infants and has no vaccine or effective antiviral therapy. Idiopathic pulmonary fibrosis, a condition that causes scarring in the lungs, causes 30,000 to 40,000 deaths in the United States each year. A lung transplant is the only cure for this condition.
“Organoids, created with human pluripotent or genome-edited embryonic stem cells, may be the best, and perhaps only, way to gain insight into the pathogenesis of these diseases,” Dr. Snoeck says.
This article has been republished from materials provided by Columbia University Medical Center. Note: material may have been edited for length and content. For further information, please contact the cited source.
Chen, Y., Huang, S. X., Ana Luisa Rodrigues Toste De Carvalho, Ho, S., Islam, M. N., Volpi, S., . . . Snoeck, H. (2017). A three-dimensional model of human lung development and disease from pluripotent stem cells. Nature Cell Biology, 19(5), 542-549. doi:10.1038/ncb3510
Cancer Stem Cell Survival is Controlled by Hedgehog Signaling ProteinsNews
Research reveals that cancer stem cell survival is controlled by a specific feature of the Hedgehog signaling pathway (SHH-PTCH1), which allows cells to respond to external signals in addition to inhibiting stem cell differentiation.READ MORE
New Research Could Significantly Accelerate Drug DiscoveryNews
Scientists have developed a suite of computer programs that cull through data on structure and genomic sequencing to identify the features that distinguish one enzyme from similar enzymes. This research has the potential to significantly accelerate drug discovery, allowing scientists to develop more effective drugs, more quickly.READ MORE
New Partnership to Provide Bioanalytical and DMPK ServicesNews
Concept Life Sciences, the integrated drug discovery, development and analytical services company, and Alderley Analytical, bioanalytical Contract Research Organisation (CRO), today announced they have signed a partnership agreement to provide high-value bioanalytical and DMPK study services.